FDA Expected To Approve Esketamine Nasal Spray For Depression : Shots - Health News Three decades after Prozac arrived, a new kind of antidepressant. And it's based on the party drug "Special K."

FDA Expected To Approve Esketamine Nasal Spray For Depression

FDA Expected To Approve Esketamine Nasal Spray For Depression

  • Download
  • <iframe src="https://www.npr.org/player/embed/700014137/701053875" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

The Food and Drug Administration is expected to approve a new type of drug for depression. It is esketamine, a chemical cousin of the anesthetic and party drug ketamine.